Abstract:The association of cdk4 with D-type cyclins to form functional kinase complexes is comparatively inefficient. This has led to the suggestion that assembly might be a regulated step. In this report we demonstrate that the CDK inhibitors p21(CIP), p27(KIP), and p57(KIP2) all promote the association of cdk4 with the D-type cyclins. This effect is specific and does not occur with other cdk inhibitors or cdk-binding proteins. Both in vivo and in vitro, the abundance of assembled cdk4/cyclin D complex increases directly with increasing inhibitor levels. The promotion of assembly is not attributable to a simple cell cycle block and requires the function of both the cdk and cyclin-binding domains. Kinetic studies demonstrate that p21 and p27 lead to a 35- and 80-fold increase in K(a), respectively, mostly because of a decrease in K(off). At low concentrations, p21 promotes the assembly of active kinase complexes, whereas at higher concentrations, it inhibits activity. Moreover, immunodepletion experiments demonstrate that most of the active cdk4-associated kinase activity also associates with p21. To confirm these results in a natural setting, we examine the assembly of endogenous complexes in mammary epithelial cells after release from a G(0) arrest. In agreement with our other data, cyclin D1 and p21 bind concomitantly to cdk4 during the in vivo assembly of cdk4/cyclin D1 complexes. This complex assembly occurs in parallel to an increase in cyclin D1-associated kinase activity. Immunodepletion experiments demonstrate that most of the cellular cyclin D1-associated kinase activity is also p21 associated. Finally, we find that all three CIP/KIP inhibitors target cdk4 and cyclin D1 to the nucleus. We suggest that in addition to their roles as inhibitors, the p21 family of proteins, originally identified as inhibitors, may also have roles as adaptor proteins that assemble and program kinase complexes for specific functions.

Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1.

SUMOylation of Rb Enhances Its Binding with CDK2 and Phosphorylation at Early G1 Phase

The G1/S transition is promoted by Rb degradation via the E3 ligase UBR5

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

Role Of Cdk2 In The Sequential Phosphorylation/Activation Of C/Ebp Beta During Adipocyte Differentiation

An intermediate Rb–E2F activity state safeguards proliferation commitment

Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16

Slower CDK4 and faster CDK2 activation in the cell cycle

Cooperation between the <i>Cdk</i> inhibitors <i>p27<sup>KIP1</sup></i> and <i>p57<sup>KIP2</sup></i> in the control of tissue growth and development

Cooperation Between The Cdk Inhibitors P27(Kip1) And P57(Kip2) In The Control Of Tissue Growth And Development

APC/C prevents a noncanonical order of cyclin/CDK activity to maintain CDK4/6 inhibitor-induced arrest

Cdc25 phosphatases are required for timely assembly of CDK1-cyclin B at the G2/M transition

The Establishment of a Hyperactive Structure Allows the Tumour Suppressor Protein p53 to Function through P-TEFb during Limited CDK9 Kinase Inhibition

Migratory Localization of Cyclin D2-Cdk4 Complex Suggests A Spatial Regulation of the G1-S Transition

CDK4/6 activity is required during G 2 arrest to prevent stress-induced endoreplication

Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F

The Retinoblastoma Gene Product Regulates Progression Through the G1 Phase of the Cell Cycle

Cell-cycle inhibitors: three families united by a common cause

The oscillation of mitotic kinase governs cell cycle latches in mammalian cells

New functional activities for the p21 family of CDK inhibitors.

RB, p130 and p107 differentially repress G1/S and G2/M genes after p53 activation